Educational hub

Branded vs generic vs compounded GLP-1

Side-by-side comparison: cost, regulation, safety, availability. Plus what changed after FDA resolved the semaglutide + tirzepatide shortages in 2024.

Quick comparison table

AttributeBrandedGenericCompounded
FDA approval✓ FDA-approved (NDA)✓ FDA-approved (ANDA)✗ Not FDA-approved (compliance-based exception only)
Active ingredient identityOriginal molecule (pharma-manufactured)Bioequivalent — same molecule, lower costSame molecule — but pharmacy-prepared, not bioequivalence-tested
Cost (monthly cash)$968-$1349/mo (list)N/A for GLP-1 (no generic semaglutide/tirzepatide yet — patents into 2031+)$150-$500/mo typically
Insurance coverageMost plans cover diabetes use; weight loss highly plan-dependentN/A for GLP-1Almost never covered — cash-pay route
RegulationFDA NDA pathway (full clinical trials)FDA ANDA (bioequivalence demonstrated)State boards of pharmacy + FDA 503A/503B framework
Quality controlGMP manufacturing + lot-level FDA oversightGMP manufacturing + FDA oversightVariable — pharmacy-specific. Reputable pharmacies use 503B GMP standards.
AvailabilityDirect from manufacturer + pharmacies. Historical shortages of semaglutide + tirzepatide resolved 2024.Not available for GLP-1Available, but FDA tightened access after shortage resolution. Now requires medical-necessity exception.
Dose optionsFixed pen doses per FDA labelN/AFlexible — pharmacy can compound custom doses
Sterility testingLot-level by manufacturerLot-level by manufacturerRequired by 503A/503B regulations; verify the certificate of analysis (COA)
Legal exposure for patientNoneNoneNone for patient if prescriber documents medical-necessity exception properly

When does each make sense?

Branded

You have commercial insurance covering brand-name GLP-1 (typical Mounjaro / Ozempic copay $25-$150/mo with PA).

You qualify for manufacturer savings (LillyDirect Zepbound $349/mo cash, Wegovy Direct $499/mo).

You want maximum regulatory protection + lot-level FDA oversight.

Generic

Not an option for GLP-1 as of 2026. Patents extend to 2031+ for semaglutide and tirzepatide.

For other classes (HRT estradiol, metformin, paroxetine), generics are widely available + cheap ($5-$30/mo).

Compounded

You have a documented medical-necessity exception (allergy to brand inactive ingredient, OR a dose not commercially available).

You're paying cash + need a lower-cost option ($150-$500/mo typical).

You've verified the pharmacy is 503A or 503B licensed + has a certificate of analysis (COA).

FAQ

Is there a generic Ozempic / Wegovy / Mounjaro / Zepbound?

Not as of 2026. Semaglutide and tirzepatide patents extend into the 2030s. No FDA-approved generic exists. Compounded preparations contain the same active molecule but are not classified as generics.

Is compounded semaglutide the same as Ozempic / Wegovy?

Same active molecule (semaglutide). Different manufacturer (pharmacy vs. Novo Nordisk), different formulation (compounders often use saline or BAC water + L-carnitine combo), and not FDA-approved. Bioequivalence is not tested. Quality varies by pharmacy.

Why is compounded GLP-1 cheaper?

No NDA / clinical trial cost recovery. No manufacturer profit margin. Pharmacy-direct preparation. The trade-off is regulatory: less FDA oversight, more pharmacy-dependent quality.

Can I switch between branded and compounded?

Yes, with prescriber guidance. Most clinicians prefer titrating up onto whichever formulation you'll stay on long-term, to avoid switching mid-titration. Compounded doses may not match brand-name dose tiers exactly.

Is compounded GLP-1 legal in 2026?

Legal only when a medical-necessity exception applies (allergy to brand inactive ingredient OR a dose not commercially available). After the FDA declared shortages "resolved" in 2024, blanket compounding is no longer permitted. Patients seeking compounded GLP-1 should consult a prescriber who documents the rationale.

Next steps